All Comments by Jürgen Götz
- Dopamine inhibits mitochondrial motility in hippocampal neurons.
- Amyloid precursor protein trafficking, processing, and function.
- Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus.
- Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.
- Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome.
- Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.
- Quality control of mitochondria: protection against neurodegeneration and ageing.
- Retinal tau pathology in human glaucomas.
- Sedimentation studies on human amylin fail to detect low-molecular-weight oligomers.
- The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.
- Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.
- Alzheimer's disease: advances in trafficking.
- Inhibition of protein aggregation: supramolecular assemblies of arginine hold the key.
- Presenilin: running with scissors in the membrane.
- Gene expression profiling in the adult Down syndrome brain.